Skip to content

Medical-device intelligence

QFO: Zika Virus Serological Reagents

FDA product code QFO: Zika Virus Serological Reagents. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
QFO
FDA device name
Zika Virus Serological Reagents
Device class
2
Regulation number
866.3935
Medical specialty
Microbiology
Review panel
MI

FDA definition

Zika virus serological reagents are devices that consist of antigens and antisera for the diagnosis of Zika virus infection in human clinical specimens from individuals that have signs and symptoms consistent with Zika virus infection and/or epidemiological risk factors. The device aids in the presumptive clinical diagnosis of Zika virus infection in conjunction with other clinical and laboratory findings.
Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

3 clearance records and 0 recall records in the covered releases, across 3 source company names and 1 product codes. Dated history runs from Jul 17, 2019 to Jun 3, 2020.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
QFO · Zika Virus Serological Reagents30

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

3 matching records
Device / recordCompany in FDA recordSourceSource date
DPP Zika IgM System, DPP Zika IgM System Control Pack, and DPP Micro ReaderK200506 · QFOChembio Diagnostic Systems510(k)Jun 3, 2020FDA decision date
LIAISON XL Zika Capture IgM II and LIAISON XL Zika Capture IgM II Control SetK192046 · QFODiaSorin, Inc.510(k)Oct 28, 2019FDA decision date
ADVIA Centaur Zika test, ADVIA Centaur Zika Ab (100 tests), ADVIA Centaur Zika IgM (50 tests), ADVIA Centaur Zika Ab Quality Control, ADVIA Centa…K191578 · QFOSiemens Healthcare Diagnostics, Inc.510(k)Jul 17, 2019FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗